Characterization of Common Genetic Variants in Cathepsin K and Testing for Association With Bone Mineral Density in a Large Cohort of Perimenopausal Women From Scotland

BMD values in ∼3000 perimenopausal Scottish women were adjusted by regression to identify and account for nongenetic factors. Adjusted BMD values were not associated with simple tandem repeat (STR) markers or single nucleotide polymorphisms (SNPs) at the Cathepsin K (CTSK) locus. We present a thorough analysis of common CTSK polymorphisms and genetic relatedness among CTSK haplotypes.

[1]  N. Freimer,et al.  Microsatellites: evolution and mutational processes. , 2007, Ciba Foundation symposium.

[2]  S. Cummings,et al.  Clinical use of bone densitometry: scientific review. , 2002, JAMA.

[3]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[4]  Y. Ru,et al.  A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. , 2002, Bone.

[5]  J. Dumas,et al.  Discovery and parallel synthesis of a new class of cathepsin K inhibitors. , 2001, Bioorganic & Medicinal Chemistry Letters.

[6]  Y. Ru,et al.  Potent and Selective Inhibition of Human Cathepsin K Leads to Inhibition of Bone Resorption In Vivo in a Nonhuman Primate , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  E. Vuorio,et al.  Accelerated Turnover of Metaphyseal Trabecular Bone in Mice Overexpressing Cathepsin K , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Y. Ru,et al.  Cyclic ketone inhibitors of the cysteine protease cathepsin K. , 2001, Journal of medicinal chemistry.

[9]  J. Falgueyret,et al.  Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. , 2001, Journal of medicinal chemistry.

[10]  Daniel L. Koller,et al.  Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. , 2000, The Journal of clinical endocrinology and metabolism.

[11]  M. Uhlén,et al.  Single-nucleotide polymorphism analysis by pyrosequencing. , 2000, Analytical biochemistry.

[12]  D. Turk,et al.  Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo. , 2000, Biochemical and biophysical research communications.

[13]  P. Sham,et al.  Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.

[14]  I. Kola,et al.  Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  I. Kola,et al.  An animal model for pycnodysostosis: the role of cathepsin K in bone remodelling. , 1999, Molecular medicine today.

[16]  C I Amos,et al.  Comparison of linkage-disequilibrium methods for localization of genes influencing quantitative traits in humans. , 1999, American journal of human genetics.

[17]  T. Ideker,et al.  Mining SNPs from EST databases. , 1999, Genome research.

[18]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. DesJarlais,et al.  Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K. , 1998, Journal of medicinal chemistry.

[20]  R. W. Davis,et al.  Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. , 1997, Genome research.

[21]  J. Ott.  Genetic data analysis II , 1997 .

[22]  S. Weremowicz,et al.  Structure and chromosomal assignment of the human cathepsin K gene. , 1997, Genomics.

[23]  C. Debouck,et al.  Genomic organization and chromosome localization of the human cathepsin K gene (CTSK). , 1997, Genomics.

[24]  Jian Zhang,et al.  Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. , 1996, Biochemical and molecular medicine.

[25]  W. G. Hill,et al.  Genetic Data Analysis II . By Bruce S. Weir, Sunderland, Massachusetts. Sinauer Associates, Inc.445 pages. ISBN 0-87893-902-4. , 1996 .

[26]  E. Vuorio,et al.  Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development , 1996, FEBS letters.

[27]  B. Gelb,et al.  Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency , 1996, Science.

[28]  C. Debouck,et al.  Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*) , 1996, The Journal of Biological Chemistry.

[29]  D. Mcnulty,et al.  Proteolytic Activity of Human Osteoclast Cathepsin K , 1996, The Journal of Biological Chemistry.

[30]  D. Brömme,et al.  Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts , 1996, The Journal of Biological Chemistry.

[31]  D. Brömme,et al.  Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. , 1995, Biological chemistry Hoppe-Seyler.

[32]  G. Bilbe,et al.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. , 1995, Biochemical and biophysical research communications.

[33]  Y. Rogers,et al.  Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms. , 1994, Nucleic acids research.

[34]  R. Lewontin.  The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models. , 1964, Genetics.

[35]  G. Caetano-Anollés,et al.  DNA markers : protocols, applications, and overviews , 1997 .